DiabetologyNews.net

Diabetology Xagena

Xagena Mappa
Medical Meeting
Pneumobase.it
Reumabase.it

Researchers at University of Utah have taken a potentially powerful new therapy for treating diabetes, peripheral vascular disease, and other illnesses out of the test tube and into animals by demons ...


For people with type 2 diabetes, the death rate from a first myocardial infaction is two to three times the death rate of patients without the disease. Similarly, patients with diabetes and ischemic h ...


A study, published in the Archives of Pediatrics & Adolescent Medicine, found that children with type 1 diabetes who exercise regularly may have improved blood glucose levels compared with those who d ...


A Gardenia fruit extract traditionally used in Chinese medicine to treat the symptoms of type 2 diabetes does indeed contain a chemical that reverses some of the pancreatic dysfunctions that underlie ...


A study, published in The New England Journal of Medicine ( NEJM ) has revealed that elevated levels of a molecule called RBP4 ( retinol binding protein 4 ) can foretell early stages in the developmen ...


Thiazolidinediones, or glitazones, are drugs commonly prescribed to patients with type 2 diabetes. Current FDA ( Food and Drug Administration )-approved agents are known as Pioglitazone ( Actos ) and ...


Researchers at the University of Pittsburgh Graduate School of Public Health ( GSPH ) discovered that while cases of premature death and a few other complications have declined, rates of other serious ...


The antidepressant Sertraline ( Zoloft ) may reduce the risk of recurrent depression and increase the period of time between episodes of depression in patients with diabetes. One of every four pati ...


Results from an analysis of pooled data from two, three-year phase 3 trials showed that Ruboxistaurin ( Arxxant ) reduced the risk of sustained moderate vision loss by 41 percent when compared to pla ...


Phase III studies demonstrated that Sitagliptin ( Januvia ), an investigational oral, once-daily medicine for type 2 diabetes, significantly reduced blood glucose levels when used as monotherapy or as ...


A two-year study has shown that Exenatide ( Byetta ) injection sustained improvements in blood glucose control and reduced body weight in people with type 2 diabetes who previously did not achieve ade ...


Vildagliptin ( Galvus ), a new once-daily oral treatment option for type 2 diabetes, has demonstrated efficacy, especially in patients with poor glycemic control, as well as weight loss benefits in ob ...


Losing a modest amount of weight through dietary changes and increased physical activity reduces the occurrence of urinary incontinence ( UI ) in women with prediabetes. This finding comes from a n ...


The brain plays a major role in the ability of insulin therapy to lower blood glucose in animals with diabetes. " Our findings suggest that, in individuals with diabetes, the ability of insulin to ...


Losing a modest amount of weight through dietary changes and increased physical activity reduces the occurrence of urinary incontinence in women with prediabetes. This finding comes from a new stud ...